Antilipolytic drug boosts glucose metabolism in prostate cancer

INTRODUCTION: The antilipolytic drug Acipimox reduces free fatty acid (FFA) levels in the blood stream. We examined the effect of reduced FFAs on glucose metabolism in androgen-dependent (CWR22Rv1) and androgen-independent (PC3) prostate cancer (PCa) xenografts. METHODS: Subcutaneous tumors were pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andersen, Kim Francis, Divilov, Vadim, Koziorowski, Jacek, Pillarsetty, NagaVaraKishore, Lewis, Jason S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662867/
https://ncbi.nlm.nih.gov/pubmed/23454248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nucmedbio.2013.01.008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares